menu

COMING Soon

ABOUT


SummitDX is developing saliva liquid biopsy tests for the early detection of Head and Neck cancer. SummitDX is an early-stage molecular diagnostics company built on the research discoveries of Drs. Shi-Long Lu and John Song, and is being spun out from the University of Colorado Anschutz Medical Campus. The company’s lead product in development is HNKlear, the first non-invasive, saliva test for Head and Neck cancer recurrence. Our test has demonstrated exciting preliminary results: detection of cancer recurrence up to one year earlier than current clinical practice. The real-time nature of our test will provide more timely and precise recurrence detection, which could lead to better treatment and improvements in patient survival.

CONTACTS

SummitDX
12635 E. Montview Boulevard, Suite V-19
Aurora, Colorado 80045 USA
Email: bob.blomquist@summitdx.com